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Abstract
The identification and determination of transformation prod-
ucts (TPs) of pharmaceuticals is essential nowadays, in order to
track their fate in the aqueous environment and, thus, to esti-
mate the actual pollution. However, this is a challenging task
due to the necessity to apply high-resolution instruments enable
to detect known and unknown compounds. This work presents
the use of liquid chromatography quadrupole time-of-flight
mass spectrometry (LC-QTOF-MS) as a powerful tool for the
identification of three selected pharmaceuticals, furosemide
(FUR), ibuprofen (IBP), and ketoprofen (KET), and their TPs
in various water samples. Laboratory degradation experiments
were performed using xenon lamp as a source of the irradiation
in order to simulate phototransformation processes which may
occur in the environment. Furthermore, the photodegradation
kinetics of three selected compounds were assessed in a reactor
equipped with xenon lamp in river water samples. Five TPs of
IBP, seven of KET, and five of FUR were identified; some of
them are presented here for the first time. Accurate mass
measurements and fragmentation pattern obtained during an
LC-QTOF-MS analysis allowed for structure elucidation of
TPs followed by the creation of transformation pathway of
selected pharmaceuticals. Finally, different water samples
(wastewater influent and effluent, river water, untreated and
treated water) were analyzed in order to estimate the pres-
ence of parent and transformed compounds. Only KETwas
detected in untransformed form in considered samples.
Most of the TPs of selected drugs were found at least once
in all water samples. Although IBP and FUR were not
present in water samples as parent compounds, their differ-
ent TPs occur. A great potential of LC-QTOF-MS in the
identification and structural elucidation of TPs in the envi-
ronment, allowing the recognition of the fate of pharma-
ceuticals in the environment through the determination of
transformation pathway, has been presented.
Keywords Pharmaceuticals . Irradiation . Aqueous
environment . Transformation products . Transformation
pathway
Introduction
Pharmaceutically active compounds (PhACs) have become an
increasingly serious problem in recent years due to their
continuous introduction to environmental waters from waste-
water treatment plants (WWTPs) [1, 2]. Global consumption
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Elucidation of transformation pathway of ketoprofen,
ibuprofen, and furosemide in surface water
and their occurrence in the aqueous environment using
UHPLC-QTOF-MS
of PhACs and their use in human and veterinary medicine are
now at an extremely high level. Once xenobiotics reach
WWTPs, the fate of PhACs in the aquatic system can be
divided into four ways [3]:
1. After series of transformations compounds are mineral-
ized and organic matter is converted into simple inorganic
compounds;
2. A compound, depending on its properties, may be less
prone to degrade. If it has the physicochemical properties
which enable to bind to the solid phase (i.e., hydropho-
bicity, lipophilicity), it may be partly accumulated in the
sludge. In consequence, sorption will affect the ability to
eliminate the compound during the treatment processes.
3. The compound can be transformed into a more lipophilic
derivative than the primary compound, which is present in
wastewater effluent.
4. A compound, which is stable and polar, is not retained or
degraded in WWTPs and thus reaches the aquatic
environment.
The problem of the PhAC presence in the effluent is that
these compounds are generally stable. As far as it is a desirable
property in medicine, it is redundant during wastewater treat-
ment due to the limited removal of PhACs during biodegra-
dation processes in conventional WWTP. However, the envi-
ronmental degradation of compounds, such as biodegradation,
photodegradation, and hydrolysis, may occur and depends on
their chemical structure as well as weather conditions. These
processes substantially reduce the potential of the compound
to induce pharmacological effect; however, the formed trans-
formation products may exhibit a similar activity and be more
stable than the parent compound [4]. The exact risks associ-
ated with accurate and chronic exposure to random combina-
tions of low levels of PhACs are not yet evaluated, although it
may cause adverse effects on aquatic organisms. Since the
level of pharmaceuticals is not regulated by law and they are
considered as threat to the environment [5], attention has been
paid to the environmental fate of these compounds in order to
improve their efficient removal from WWTPs and prevent
from continuous introduction of PhACs to aqueous
environment [6].
Disinfection of drinking water and wastewater can be
performed via ozonation, chlorination, or UV irradiation.
The last one is often employed in water treatment plants
(WTPs) due to its effectiveness in removing viruses and
bacteria [7]. In Poland, the application of UV irradiation is
rather limited due to high cost of the investment and mainte-
nance. Although ultraviolet light has an additional advantage
of removing PhACs [8], it can contribute to creating
photodegradation intermediates that are more persistent or
toxic than the parent analyte [9]. Laboratory experiments
applying sunlight or mercury-vapor lamps on PhACs have
proved that diclofenac, naproxen, ibuprofen, ketoprofen, and
atenolol are susceptible to photodegradation in water samples
(pure water river water, wastewater) [9, 10]. However, the
degradation rates vary between studies what can be attributed
to susceptibility of the compound to photolysis, matrix, and
the type of the irradiation source. The phototransformation is
considered as a potentially significant process in the degrada-
tion of pharmaceuticals [10] and involves direct photolysis (a
compound absorbs the light by itself) and indirect photochem-
ical reactions of a compound with active molecule, e.g., ·OH,
1O2, ROO·,
3DOM*, and e−aq (that are generated by photo-
sensitizers such as dissolved organic matter) [11, 12]. Under
constant UV irradiation, degradation reactions are typically
first order.
The pharmaceuticals (ketoprofen, ibuprofen—nonsteroidal
anti-inflammatory drugs; furosemide—diuretic) chosen for
this study were compounds which differ in term of chemical
structure and were found in wastewater and river water in high
concentrations (up to micrograms per liter [13, 14]). Little
information is available on transformation products (TPs) of
these compounds because most of the available reports are
focused rather on parent compounds. While the awareness
grows, the need for elucidating environmental fate of PhACs
increases as well. The photodegradation of ketoprofen, ibu-
profen, and furosemide has been briefly studied, mostly in
pure water, surface water, and wastewater [9, 15, 16]. How-
ever, studies on TPs should be more accurate and extended to
assess proper identification and elucidation of the structure of
TPs and finding the pathway of their transformation in order
to monitor the presence of transformed analytes in environ-
mental water samples since some of the TPs were proved to be
toxic [6, 17, 18].
Identification of TPs is based on suspected and nontarget
screening what requires instruments generally with high-
resolution and accurate mass measurements. To meet the
present expectations of identifying known–unknown com-
pounds at low concentrations in complex matrices, the cou-
pling of liquid chromatography to high resolution mass accu-
racy (LC-HRMS) has become a powerful tool [19]. Such
instruments as LC-quadrupole time-of-flight mass spectrom-
etry (LC-QTOF-MS) are able to performMS/MS experiments
for obtaining full scan product ion spectra with accurate
masses of fragment ions and thus provide structural informa-
tion of the compound [20, 21]. The structure of identified
compound is verified by comparing changes in exact molec-
ular mass and masses of fragment ions which origin from
parent ions [22]. Providing a reliable data is very important
due to avoiding false-positive findings, and thus, high-
resolution mass spectrometers such as QTOF-MS are
required.
In light of these concerns and lack of literature data pre-
senting the importance of degradation as a probable transfor-
mation pathway of PhACs, the aim of this study was to
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investigate the degradation kinetics and identification of TPs
of chosen pharmaceuticals by UV/VIS irradiation in natural
water samples. In the present study, the photodegradation
kinetics of ibuprofen, ketoprofen, and furosemide was
assessed in a reactor equipped with xenon lamp in river water
samples. Furthermore, the TPs of each compound were iden-
tified with the application of LC-QTOF-MS. To the best of our
knowledge, this is the most extensive study of TPs of ibupro-
fen, ketoprofen, and furosemide including kinetics and struc-
ture elucidation followed by proposing photodegradation
pathways for each compound. Five degradation products of
ibuprofen (IBP), seven products of ketoprofen (KET), and
five of furosemide (FUR) were identified together with their
structures. Some of these compounds are reported here for the
first time following with new transformation pathways. Fur-
ther monitoring of identified compounds in different water
samples was carried out. The application of LC-HRMS pro-
vided the necessary confirmation due to the mass accuracy




Analytical standards of IBP, KET, and FUR were purchased
from Sigma-Aldrich (Poznań, Poland). LC-MS grade metha-
nol (MeOH) was obtained from Sigma-Aldrich (Poznań, Po-
land). Formic acid was from Merck (Warsaw, Poland). Ultra-
pure water was obtained from an HLP5 system (Hydrolab,
Poland). MeOH used for extraction were LC grade and were
purchased from Merck (Warsaw, Poland). Individual stock
solutions of each compound at concentration level of 1 g/L
were prepared in methanol and were stored at −80 °C.
The irradiation experiment
All degradation experiments were performed using a small-
scale system that consisted of a cylindrical photoreactor
(25 mL) equipped with quartz window and cooling system,
external light system, and optical filters (Fig. 1). The irradia-
tion was emitted by 1,000 W xenon lamp (627H, Oriel) and
transmitted light of wavelength in range 250–1,000 nm due to
the optical filters (UG1, Schott AG) used for cutting off the IR
irradiation. Similar equipment was previously applied by
Górska et al. [23] for photodegradation of phenol.
The temperature of the samples during the experiment was
maintained at 10 °C. The photodegradation experiment was
performed for each compound separately in river water free
from the targets while providing the same experimental con-
ditions. The initial concentration of chosen compounds (ibu-
profen, ketoprofen, and furosemide) was 1 mg/L for both
kinetic study and identification of TPs. Higher initial concen-
tration of analytes increased the possibilities of proper identi-
fication and structure elucidation of TPs. Twenty-five millili-
ters of aqueous sample containing one of the compounds was
stirred magnetically during the irradiation. Aliquots of about
500 μL were collected during the experiment at specific
intervals dependent on the compound (total degradation time
was different for each analyte), filtered through a 0.45-μm
nylon syringe filter (Rockwood, USA), and subjected to ultra
performance liquid chromatography (UPLC)-QTOF-MS
analysis for further data evaluation.
Analytical procedure
Analyses were performed on Agilent 1290 UPLC system
(G4226A autosampler, G1312C binary pump and G1316A
thermostated column). The separation of analytes was done
using XTerra MS C18 (30×2.1 mm; 3.5 μm). The mobile
phase A was ultrapure water with 0.05 % FA and B was
MeOH at a flow rate 0.4 mL/min. The gradient started from
95%A to 0 %A in 15min, back to 95%A in 1 min, and kept
at 95 %A for 5 min. The column was maintained at 22 °C and
the injection volume was 5 μL.
The UPLC system was connected to a hybrid QTOF mass
spectrometer (Agilent 6540 Series Accurate Mass QTOF-MS)
operated in negative ion mode. Ions were generated using a
dual ESI ion source. Operation conditions were as follows:
sheath gas temperature 400 °C at flow rate of 12 L/min,
capillary voltage 4,000 V, nebulizer pressure 20 psig, drying
gas 10 L/min, gas temperature 325 °C, skimmer voltage 45 V,
octopole RF peak 750 V, and fragmentor voltage 100 V.
Analyses were performed using MS/MS or AutoMS/MS
mode with fixed collision energy and in mass range of 50–
1,000 m/z. The instrument was operated in the 4-GHz high-
resolution mode. Acquisition rate was 1.5 spectra/second.
Acquisition data were processed with Agilent MassHunter
Workstation software.
Sample collection and preparation
Aqueous samples collected from the Gdańsk area where influ-
ent and effluent water samples were from aWWTP, treated and
untreated water from a WTP, and river water from Radunia
River exposed to anthropogenic activity. All samples were
collected in prerinsed amber glass bottles and filled to the brim
to reduce analyte transition to the gas phase. After immediate
transportation to the laboratory, they were stored at 4 °C and
analyzed within 24 h. Environmental water samples were
screened for the presence of identified compounds.
Sample preparation was based on solid phase extraction
(SPE) and was performed using Oasis HLB cartridges
(200 mg, 6 mL; Waters). SPE cartridges were preconditioned
with 5 mL of MeOH and 5 mL of ultrapure water. Before
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loading, 1 mL 0.1 M EDTA/100 mL sample was added. A
volume of 100 and 200 mL of influent and effluent, respec-
tively, and 500 mL of treated, untreated water, and river water
were loaded on the sorbent at a flow rate of 5 mL/min (in case
of extraordinary contaminated samples with solid particles,
before loading, it was filtrated by a cellulose filter). The sorbent
was dried for 15 min and then the analytes retained were eluted
with 6 mL (3×2 mL) of MeOH. The extracts were evaporated
to dryness in a stream of nitrogen and residues were redissolved
in 1 mL of MeOH/H2O (1:9, v/v). Five microliters of this
solution was injected into the UPLC-QTOF-MS system.
Results and discussion
Photodegradation kinetics in river water
The photodegradation of the three studied compounds in river
water followed a pseudo-first-order kinetics (Fig. 2). The
time-based pseudo-first-order rate constants (k) were deter-





where Ct is the concentration of the compound at the irradia-
tion time t and C0 is the initial concentration of the analyte.
The results were plotted using the natural logarithm of the
analyte concentration as a function of time. Pseudo-first-order
photodegradation rate constants were determined by regres-
sion analysis. Half-lives t1/2 were calculated using Eq. (2)





Photodegradation of selected compounds had different
time-based degradation rate constants; the value of the con-
stant kwas one and three orders of magnitude higher for FUR
and KET, respectively, than IBP (Table 1). After a different
time of irradiation, analytes reached a final concentration level
below detection limit. KET was undetectable after 60 s of
Fig. 1 A small-scale system
applied during the irradiation
experiment
Fig. 2 Degradation kinetics of a ketoprofen, b furosemide, and c ibupro-
fen in river water
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exposition to Xe lamp light, FUR after 60 min, and IBP was
the most persistent one degrading after 13 h of irradiation.
Absorption spectra of KET (λmax=205 and 255) and FUR
(λmax=228 and 275) overleap the Xe lamp emission spectrum
which has an important influence on their degradation. On the
other hand, the small absorbance in the UV region for IBP
(λmax=222) helps to explain why its photodegradation was
less efficient relatively to KETand FUR.
Overall, these parameters allow assuming that these com-
pounds are probable to degrade at the wavelength range used
and, as presented in this study, indicate a higher degradation
potential for ketoprofen, followed by furosemide and then
ibuprofen (Table 1 and Fig. 2).
Phototransformation of selected pharmaceutical
In order to identify reaction products of the target compounds,
samples collected at various time intervals were analyzed by
LC-QTOF-MS. Exposure of the drug solutions in the river
water to light allowed simulation of conditions naturally oc-
curring in the environment. This was possible because Xe
lamp emits continuous concentrated light which wavelength
range overlaps the sunlight spectra (250–1,000 nm) that in-
cludes ultraviolet light, visible light, and near infrared light.
Preliminary identification of the probable TPs was based on
accurate mass measurements of the parent ion with a mass
error <5 ppm in the full scan acquisition mode. To provide
reliable confirmation of TPs during laboratory degradation
experiment, further accurate MS/MS measurements were per-
formed in order to observe characteristic fragmentation ions of
the parent compound. Such approach is a safe way for an
accurate identification and is helpful in the structure elucida-
tion, especially in case the compounds are not present in a
library.
The irradiation of the pharmaceuticals resulted in the forma-
tion of new chromatographic peaks corresponding to several
TPs generated during the photodegradation processes. Five
degradation products of IBP photolysis, seven products of
KET, and five of FUR were identified and, in detail, are
presented in Table 2. The TPs of the chosen pharmaceuticals
were tentatively identified by extracted ion chromatograms
using a 10-ppm error window while performing full scan
analysis. As presented in Table 2, the experimental mass (m/z)
deviation from the theoretical molecular masses for
deprotonated [M-H]− structural transformation compounds
ranged from −5.4 to 5.1. The accurate mass MS/MS spectra
of all compounds (Electronic Supplementary Material,
Figs. S1, S2, and S3) were obtained by selecting the
deprotonated molecule [M-H]− at a specific m/z value as a
precursor ion to yield the fragmentation pattern and thus to
obtain the structural information of the compound. Accurate
mass measurements with low mass error together with frag-
mentation pattern of TPs provided by LC-QTOF-MS analysis
were the most important while elucidating structures and the
transformation pathway of selected pharmaceuticals.
Identification and confirmation of IBP degradation products
through laboratory degradation experiment
The first product of degradation has been found immediately
after preparation of its solution in river water, before exposure
to light. The most important fragment in the mass spectrum of
product IBP 1 is the ion ofm/z161.1335, which corresponds to
decarboxylation of the parent molecule. Due to the fact that this
product appeared quickly and without exposure to light, we
assumed that its formation is probably caused by transforma-
tion processes, which may occur in river water (e.g., hydroly-
sis), rather than photolytic degradation. It must be noted that
this degradation product (IBP 1) is already known in the
literature as the product formed after photodegrative destruc-
tion as reported by Caviglioli et al. [24] for the chemical
oxidation of this drug with permanganate, dichromate, and
concentrated H2O2, by Skoumal et al. [25] for the electrochem-
ical by electro-Fenton and photoelectro-Fenton degradation, by
Szabo et al. [26] during the UV (254 nm) and vacuum ultravi-
olet UV/VUV (254/185 nm) photolysis, and by Mendez-
Arriaga et al. [27] by heterogeneous TiO2 photocatalysis.
Exposition of the ibuprofen solution to Xe lamp light
caused formation of the second degradation product (IBP 2)
after 1.5 h. This product with the m/z value 177.1291 may
correspond to mono-hydroxylated derivative of compound
IBP 1. During the irradiation of river water with Xe lamp,
hydroxyl radicals and other oxidants are formed according to
the following reactions [28]:
H2Oþ UV→H˙ þ OH˙
OH ˙ þ OH ˙ →H2O2
H ˙ þ O2→ HO2˙
Consecutive reaction of the hydroxyl radical could take
place either at the benzyl position of its isobutyl or ethyl
substituents, on the tertiary carbon atom position of isobutyl
side chain (group), or may occur directly at aromatic ring to
give 1-(4-ethylphenyl)-2-methylpropan-1-ol, 1-(4-
isobutylphenyl)ethanol, 1-(4-ethylphenyl)-2-methylpropan-2-
ol, or 1-ethyl-4-isobutylphenol (IBP 2a, IBP 2b, IBP 2c, IBP
2d), respectively. Unfortunately, in our experiments, the exact
Table 1 Photodegradation rate constants (k), half-lives (t1/2), and irradi-
ation time for IBP, KET, and FUR in river water
Compound k (min-1) t1/2 (min) tirradiation (min)
IBP 0.0039 180 780
KET 1.8 0.4 5
FUR 0.030 23 60
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structure of the products can not be confirmed by fragmentation
ions but the photodegradation products IBP 2a, b, and c have
been already identified in the literature [18, 26, 27, 29]. The
subsequent degradation product IBP 3 of m/z value 159.1183
may correspond to 1-isobutyl-4-vinylbenzene, which is formed
by elimination of formic acid (HCOOH group) from ibuprofen
Table 2 Identification of transformation products generated by Xe lamp photodegradation of IBP, KET, and FUR
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molecule or by dehydratation of product IBP 2b. This pathway
has not yet been described in the literature.
Continued irradiation of the ibuprofen solution revealed
formation of another degradation product (IBP 4, m/z value
221.1193). This compound was assumed to be the result of
hydroxylation of the ibuprofen molecule still present in solu-
tion by OH· radical. Hydroxylation may occur at the site of the
molecule most susceptible to attack of the radical as well, i.e.,
at one of the two benzyl positions, at the tertiary carbon atom
position or at the aromatic ring, as it was mentioned earlier.
For that reason, four derivatives of IBP 4 molecule (IBP 4a,
4b, 4c, 4d) can be expected. All of these products have been
already reported in the literature. 2-[4-(1-Hydroxy-2-
methylpropyl)phenyl]propanoic acid (IBP 4a) and 2-
hydroxy-2-[4-(2-methylpropyl)phenyl]propanoic acid (IBP
4b) have already been identified by Skoumal et al. [25] during
the photoelectro-Fenton degradation and by Madhavan et al.
[30] for sonophotocatalysis degradation, whereas product IBP
4c (2-[4-(2-hydroxy-2-methylpropyl)phenyl]propanoic acid)
and IBP 4d (2-[hydroxy-4-(2-secbutyl)phenyl]propanoic acid)
have been detected by Illes et al. [18] and by Mendez-Arriaga
et al. [27] in heterogeneous TiO2 photocatalysis and in radi-
olysis. The final detected product IBP 5 has been formed
already after 10 min of irradiation. Its concentration in exam-
ined solution continuously increased during exposition to Xe
lamp light, whereas the concentration of ibuprofen simulta-
neously decreased. IBP 5 molecule with the m/z value of
273.1120 and fragmentation ions m/z 161.1336 and m/z
205.1242 characteristic for ibuprofen suggest that it may be
the product of photodegradation of ibuprofen. Unfortunately,
we are not able to predict its structure and the pathway.
Ibuprofen dimer (m/z 411.2541) and its adduct with sodium
(m/z 433.2360) were observed as well; however, these com-
pounds were considered as products formed as a result of
electrospray ionization rather than phototransformation. This
is due to the fact that dimer and its adduct are observed since
the beginning of the experiment and their concentration de-
creases proportionally to the decrease of IBP concentration.
Products detected by LC-QTOF-MS formed during the
photocatalytic treatment and possible transformation path-
ways of ibuprofen in the aqueous environment are presented
in Fig. 3.
Table 2 (Continued)
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Identification and confirmation of KET degradation products
through laboratory degradation experiment
As it has been previously mentioned, ketoprofen had under-
gone photodegradation easier and with higher reaction rate
than ibuprofen. The first degradation product (KET 1) has
been identified after 10 s of the exposure of the ketoprofen
solution to Xe lamp light. The structure corresponding to ion
m/z 209.0972 may reveal decarboxylated ketoprofen mole-
cule, what is often suggested in the literature as the first step
of its degradation [31, 32]. The product KET 1 was complete-
ly degraded by photolytic irradiation within 80 s.
The compound KET 2 (3-(1-hydroxyethyl)benzophenone,
m/z 225.0933) observed after 30-s lamp exposition is probably
a product of hydroxylation at benzyl position of KET 1 mole-
cule. This product is described in the literature [26] as a result of
the vacuum ultraviolet photolysis. The signal from the by-
product KET 1 was no longer registered in a sample taken after
80 s of irradiation, but the presence of the compound KET 2
was still recorded. The presence of the compounds KET 3,
KET 4, KET 5, and KET 6 has also been revealed in the same
sample. The most important fragment in the mass spectrum of
product KET 3 is the ion of m/z 241.0883, which may corre-
spond to the double hydroxylation of compound KET 1 or
monohydroxylation of KET 2 at the aromatic ring. The exact
position of the hydroxyl substituent at the aryl ring cannot be
precisely established. Another detected compound KET 4 with
the m/z value 197.0612 may represent the product after the
cleavage of hydroxyethyl group from KET 3.
The appearance of compound KET 5 shows that the
3-(1-hydroxyethyl)benzophenone (product KET 2) is ox-
idized during irradiation and converted probably into 3-
acetylbenzophenone with the m/z value 223.0771. The
most important fragment in the mass spectrum of prod-
uct KET 6 is the ion of m/z 239.0720, which may
correspond to the elimination of acetyl group. Formation
of all the above-mentioned products is confirmed by the
fragmentation ions m/z 181.0670 and m/z 197.0613
which may correspond to unsubstituted benzophenone
and hydroxybenzophenone, respectively. The products KET
3, KET 4, and KET 6 have not been yet reported in the
literature.
Another detected product KET 7 has been formed
after 30 s of irradiation. Its concentration in examined
solution continuously increased during exposition to Xe
lamp light, whereas concentration of ketoprofen simul-
taneously decreased. KET 7 product with the m/z value
221.1191 and fragmentation ion m/z 177.1300 suggest
that it has been probably formed by oxidative ring
opening of the ketoprofen molecule as was previously
reported by Salgado et al. [9] for medium pressure UV
photodegradation.
Irradiation of ketoprofen solution by the xenon lamp has
been terminated after 5 min. No signals originating from
ketoprofen and its degradation product KET 1 have been
recorded then, whereas the presence of degradation products
KET 2, KET 3, KET 4, KET 5, KET 6, and KET 7 was still
detected in the examined solution.
Fig. 3 Suggested main
transformation pathway of
ibuprofen
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On the basis of the degradation products identified in this
experiment, the hypothetical ketoprofen degradation pathway
has been suggested and schematically shown in Fig. 4.
Identification and confirmation of FUR degradation products
through laboratory degradation experiment
The UVabsorption spectra of furosemide overleap the Xe lamp
emission spectrum; therefore, the photodegradation of this
pharmaceutical occurs straightforward. The proposed photoly-
sis pathway of furosemide is schematically presented in Fig. 5.
Product FUR 1 (m/z248.9750) has been detected in a sample
solution before irradiation. This product was probably obtained
by cleavage of the furanylmethyl group due to the transforma-
tion processes occurring in real water sample. The signal from
the other degradation products such as FUR 2, FUR 3, and FUR
5 has been recorded in a sample taken after 5 min of Xe lamp
treatment. The most important fragment in the mass spectrum of
product FUR 2 has the m/z 311.0327, which may correspond to
the replacement of the chlorine atom by the hydroxyl group in
the furosemide molecule. Product FUR 3 with the m/z value
295.0405 has been probably formed by dehalogenation of furo-
semide, whereas FUR 5 (m/z 231.0086) results by loss of
furanylmethyl substituent and the replacement of the chlorine
atom by the hydroxyl group. Formation of N-furfuryl-5-
sulfamoylanthranilic acid (FUR 3) has been already reported
by Vargas et al. [33] for the irradiation under oxygen atmosphere
catalyzed by the presence of human serum albumin.
Compound FUR 4 which structure corresponds to the mol-
ecule of furosemide after the dehalogenation and elimination of
Fig. 4 Suggested main
transformation pathway of
ketoprofen
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the furanylmethyl group (m/z 215.0140) has been identified in
the sample taken after 15 min of continuous exposure of the
solution. Furosemide solution was irradiated with a xenon lamp
light continuously for 1 h, that is, to the point where furosemide
molecule was completely decomposed, but identification of its
degradation products was still possible.
The immediate formation of product FUR 1 evidences that
cleavage of the furanylmethyl group from furosemide mole-
cule occurs easily. Further degradation pathways are difficult
to anticipate. FUR 5 may be formed as the result of replace-
ment of the chlorine atom by the hydroxyl group. However,
the furosemide molecule may first be substituted by hydroxyl
group giving compound FUR 2, and subsequently, it may be
deprived of the furanylmethyl group (FUR 5). The compound
FUR 5 can undergo further reaction during exposure to radi-
ation (cleavage of hydroxyl group) and in a result may give
end product FUR 4. Another way leading to FUR 4 may be
dehalogenation of furosemide to FUR 3, followed by lose of a
furanylmethyl group (FUR 4).
Dynamics of the transformation products generated
during the irradiation
The irradiation of a sample containing ibuprofen led to the
formation of the main TP product IBP 1 (Fig. 6a) which was
observed in the river water before the exposure to light sug-
gesting its creation within transformation processes such as
hydrolysis rather than photodegradation. The further degrada-
tion was observed by the proportional decrease of the amount
of IBP and IBP 1 to the increase of the level of IBP 2 and 4. As
it can be seen in the degradation pathway scheme (Fig. 3), the
transformation of either IBP to IBP 4 or IBP 1 to 2 was
probable to occur. IBP 3 was the most persistent and stable
compound that occurs in the sample right after the beginning
of the irradiation and did not degrade at any amount within the
experiment. Although it was not possible to elucidate the IBP
5 structure, it was considered as one of TPs due to the increase
of its amount while performing the experiment while IBP was
degrading.
Photolysis of ketoprofen generated three compounds
appearing in the highest amount, KET 1, 2, and 5 (Fig. 6b).
The amount of KET 1 was increasing proportionally to the
decrease of the concentration of ketoprofen; however, both
compounds degraded below detection limit after the first
minute of irradiation. The lack of KET in the solution was
not consistent with the further lack of degradation products
which were observed until 5 min exposure to Xe lamp light.
The transformation of KET 1 to KET 2 and later to KET 5was
observed after 1 min exposure, meaning after the degradation
of KET 1. The formation of two other TPs (KET 3 and 4) was
Fig. 5 Suggested main
transformation pathway of
furosemide
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observed as well. As long as the amount of KET 3 increased
slowly along irradiation time until 1 min, the content of KET 4
was observed since the beginning of the light exposure lasting
at a similar level for 3 min, and thus, this analyte was consid-
ered as a persistent compound. Avery small amount of KET 6
was noted; however, it was considered as an intermediate
degradation product which was formed from KET 3 and
directly transformed to KET 4. Additional TP was found,
KET 7, formed through the decay of the aromatic ring, which
level was increasing along the irradiation time. It was consis-
tent with degradation pathway elucidated for ketoprofen
(Fig. 4).
The phototransformation of furosemide in photodegradation
experiment in river water resulted in two main TPs (FUR 2 and
3, Fig. 6c); however, other products FUR 1, 4, and 5 were
identified at very low peak area close to LOD (S/N=3). Com-
pounds FUR 2 and 5 were considered as the most persistent
ones since their concentration level increased within first few
minutes and was stable during further irradiation. However,
when the level of FUR 2 and 5 finally started to decrease, it was
observed that the amount of the product FUR 4 increased
rapidly since it was created as a result of the transformation
of the two previous TPs. These conclusions are consistent with
the transformation pathway of furosemide (Fig. 5).
The experiment proved the formation of many TPs of
ibuprofen, ketoprofen, or furosemide; some of them appeared
persistent and were reported here for the first time. It leads to
the conclusion that tracing their occurrence in the aqueous
environment as well as in WWTPs is of a great importance
and necessary to perform. Future research on the ecotoxicity
potential of identified compounds should be conducted.
The occurrence of the selected pharmaceuticals and TPs
in aqueous environment
The presence of parent compounds and their identified trans-
formation products was determined in the waste water (WW)
influent and effluent, treated and untreated water from WTP,
and Radunia River exposed to anthropogenic activity. Screen-
ing of all compounds was performed in target MS/MS mode
Fig. 6 Relative peak area of the PhACs and corresponding TPs in the photodegradation experiment performed in river water a for ketoprofen, b
ibuprofen, and c furosemide
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for all samples using the window tolerance of 5 ppm. The
confirmation of selected pharmaceuticals and TPs in environ-
mental waters samples was accomplished by the structural
information of deprotonated parent compound obtained from
the fragmentation experiment provided by LC-QTOF-MS/MS
analysis. To avoid false-positive findings, identification of the
compounds was based on LC retention time of the analyte with
the deviation <2 %, accurate mass measurements of the parent
ion and accurate mass measurement of at least one specific
product ion together with their relative abundance with a mass
error below 5 ppm, comparing with the data obtained during
laboratory degradation experiment (Table 2). Unfortunately,
some accurate mass measurements of parent and product ions
gave mass errors higher than 5 ppm. It was acceptable as long
as MS/MS spectra were similar to those obtained during labo-
ratory photodegradation. However, it was found that in some
samples, especially WW influent, the MS/MS spectra were
unclear and some of the specific product ions were not ob-
served principally due to the masking effect of highly abundant
isobaric interferences. In such cases, it was not possible to state
unambiguously about the presence of the compound, and thus,
such results were rejected from further consideration.
Data obtained for selected pharmaceuticals and TPs on
their occurrence in various water samples are presented in
Table 3. Only ketoprofen was detected in untransformed form
in considered waters. Most of the TPs of selected drugs were
found at least once in all aqueous samples. However, FUR 5,
IBP 3, and KET 4 and 5 were not detected in any sample. WW
influent was the most contaminated by TPs derived from all
three pharmaceuticals. Considering ketoprofen, its products
KET 2 and 3 were determined most often in water samples
(18/25 samples). Surprisingly, KET 6, which was considered
as an intermediate product, was found in WW influent (5/5
samples) and effluent (2/5 samples). In the case of ibuprofen,
IBP 1 was found in almost all water samples; however, its
presence may be caused by transformation processes occur-
ring in natural waters (e.g., hydrolysis or (less probable)
biodegradation by the microorganisms present in the matrix)
rather than as a result of photolysis. TPs of furosemide were
noticed rarely; however, FUR 1 and 4 were found in treated
water (3/5 samples) what may indicate on their formation
during water treatment process.
In order to assess the degree of the elimination of pollutants
from WWTPs, it would be necessary to determine the pres-
ence of pharmaceuticals and TPs in the sewage sludge, which
particles can adsorb impurities. In such case, they will not be
present in the effluent stream; however, these compounds can
infiltrate from disposed sludge to ground water leading to its
contamination. In some cases, only TPs were detected, so the
determination of transformed compounds in the aqueous en-
vironment is justified. Contaminants can spread between
ground and surface water, which are the source of drinking
Table 3 The occurrence of selected pharmaceuticals and their TPs in various water samples
Compound Positive samples/n samples
WW influent WWeffluent Radunia river Untreated water Treated water
FUR 0/5 0/5 0/5 0/5 0/5
FUR 1 2/5 0/5 1/5 2/5 3/5
FUR 2 1/5 1/5 1/5 2/5 0/5
FUR 3 0/5 0/5 1/5 0/5 0/5
FUR 4 0/5 0/5 0/5 0/5 3/5
FUR 5 0/5 0/5 0/5 0/5 0/5
IBP 0/5 0/5 0/5 0/5 0/5
IBP 1 5/5 4/5 4/5 1/5 4/5
IBP 2 2/5 2/5 0/5 2/5 1/5
IBP 3 0/5 0/5 0/5 0/5 0/5
IBP 4 2/5 3/5 1/5 1/5 2/5
IBP 5 5/5 0/5 0/5 1/5 2/5
KET 5/5 3/5 5/5 4/5 4/5
KET 1 1/5 2/5 0/5 3/5 2/5
KET 2 1/5 3/5 4/5 5/5 5/5
KET 3 5/5 4/5 5/5 2/5 1/5
KET 4 0/5 0/5 0/5 0/5 0/5
KET 5 0/5 0/5 0/5 0/5 0/5
KET 6 5/5 2/5 1/5 0/5 0/5
KET 7 1/5 1/5 3/5 3/5 0/5
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water, and thus, the presence of pharmaceuticals and their TPs
in various water samples should be monitored.
The studies confirm that the control of the presence of
contaminants should include the knowledge of their behavior
(fate) in the aquatic environment. Absence of pharmaceuticals
in the form in which they are released to the environment does
not mean that they are not present in a transformed form. The
conducted experiment shows that furosemide and ibuprofen
were not present in the original form, but its TPs have been
identified. It is possible that the same photodegradation prod-
ucts could occur also as a result of biodegradation.
Conclusion
LC-QTOF-MS is a very powerful tool for the identification of
TPs of pharmaceuticals in the aqueous environment. Five
degradation products of IBP photolysis, seven products of
KET, and five of FUR were identified using MS/MS experi-
ment with accurate mass measurements followed by the cre-
ation of transformation pathway for each compound. To the
best of our knowledge, some of the identified compounds
along with its transformation pathway are presented for the
first time. Of major significance is the fact that these com-
pounds are repeatedly detected in the aqueous environment:
WW influent and effluent, river water, and untreated/treated
water. Actual data showed that although the original com-
pound is not present as such (IBP and FUR), their TPs are
still present what leads to the conclusion that wastewater
treatment processes are not efficient, and the impact on the
receiving waters is unfortunately unknown. Further studies
will be focused on monitoring of the environment and assess-
ment of their ecotoxicity.
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